Assyro AI

FDA Orange Book · active-ingredient family

Formoterol fumarate

Formoterol fumarate is approved as 3 brand and 10 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:PERFOROMIST · NDA 022007

3

Brand (NDA)

10

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · powder, solution

ProductApplicantApplicationTEApproved
PERFOROMISTRLDVIATRIS SPECIALTYNDA 022007ANMay 11, 2007
FORADILRLDNOVARTISNDA 020831Feb 16, 2001
FORADIL CERTIHALERNOVARTISNDA 021592Dec 15, 2006

Generic (ANDA) products (10)

ProductApplicantApplicationTEApproved
FORMOTEROL FUMARATEDEVA HOLDING ASANDA 218308ANFeb 11, 2025
FORMOTEROL FUMARATEDR REDDYSANDA 215907ANJan 30, 2025
FORMOTEROL FUMARATELEXENPHARMANDA 216426ANOct 22, 2024
FORMOTEROL FUMARATEMICRO LABSANDA 218304ANJun 26, 2024
FORMOTEROL FUMARATEMANKIND PHARMAANDA 215883ANMar 22, 2023
FORMOTEROL FUMARATEWILSHIRE PHARMS INCANDA 215621ANDec 13, 2022
FORMOTEROL FUMARATERITEDOSE CORPANDA 216486ANNov 25, 2022
FORMOTEROL FUMARATELUPINANDA 215053ANAug 22, 2022
FORMOTEROL FUMARATEALEMBICANDA 215078ANNov 22, 2021
FORMOTEROL FUMARATETEVA PHARMS USA INCANDA 091141ANJun 22, 2021

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Formoterol fumarate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.